Clinical Trial Update: Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of eslicarbazepine acetate for postherpetic neuralgia was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Post Herpetic Neuralgia | Phase 3 | Status: TERMINATED | Results posted: 2014-04-07